Globus Medical Reports First Quarter 2021 Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/1/2026
- Wall St on track for subdued September start as high yields, oil prices dent sentiment
- Oil up more than 2% as renewed US-Iran strikes stoke supply fears
- Two Saudi tankers struck in Strait of Hormuz Monday
- The Warsh pivot markets didn't expect
- Oil settles up by more than 2.5% as US and Iran resume military attacks
Globus Medical (GMED) PT Raised to $73 at Stifel
May 5, 2021 9:36 AM EDTStifel analyst Mathew Blackman raised the price target on Globus Medical (NYSE: GMED) to $73.00 (from $60.00) while maintaining a Hold rating.
The analyst commented, "We expected GMED to post a strong 1Q, but the company's near-20% growth -- despite meaningful, early 1Q COVID... More
Globus Medical (GMED) Tops Q1 EPS by 12c, Offers Guidance
May 4, 2021 4:43 PM EDTGlobus Medical (NYSE: GMED) reported Q1 EPS of $0.49, $0.12 better than the analyst estimate of $0.37. Revenue for the quarter came in at $227.3 million versus the consensus estimate of $198.39 million.
GUIDANCE:
Globus Medical sees FY2021 EPS of $1.83-$1.89, versus the consensus of $1.84.... More
